
ABOUT US
A Trusted Partner for the Biopharmaceutical Industry and Laboratories
Sartorius is a leading international pharmaceutical and laboratory equipment supplier. Our customers work hard to develop and produce drugs that cure, prevent or halt the progress of diseases. To be successful in their endeavors, they rely on partners who understand their current and future challenges. For 150 years, the Sartorius brand has stood for innovative products and solutions that support the work of scientists and engineers worldwide. In doing so, we have increasingly focused on enabling breakthroughs in life science research and biomanufacturing. Sustainability, Openness, Enjoyment - these corporate values are the foundation for innovation and competitive strength at Sartorius. Our values connect us with our customers and business partners just as they do with our investors and society at large - worldwide.
Accelerating Drug Discovery and Simplifying Production
Biopharmaceuticals are produced using living cells in complex and expensive procedures. With our innovative products and services, we enable pharmaceutical researchers and lab personnel to simplify workflows, minimize human errors and speed up their work. We provide solutions that shorten the lengthy and difficult search for active ingredients. For example, new methods for cell analysis help to unlock the great potential of new therapeutic approaches, and software converts data into safe, actionable insights.
Furthermore, manufacturing technologies must also evolve to accelerate the process of taking these innovations from the lab to the clinic to increase patient access. Innovation in upstream & downstream process technologies are needed to improve the efficiency and cost of bio-manufacturing to ultimately make new promising medicines affordable.
Sartorius is part of the solution. Our technologies help simplify and accelerate biopharmaceutical process development through to commercial manufacturing. Designed with a focus on scalability, safety and robustness, we deliver end-to-end solutions and partner with manufacturers to develop optimal process designs specifically fit to their needs. In fact, Sartorius has been pioneering and setting the standards for single-use products that are currently used throughout all biopharmaceutical manufacturing processes. We help our customers to bring medications safely and quickly to the patient.
Corporate Social Responsibility
Sustainability is one of the core values firmly anchored in Sartorius’s corporate culture. It is our primary entrepreneurial responsibility to offer our customers attractive products and solutions. Innovation as well as strategic and operating excellence are the keys to accomplishing this mission. To us, sustainability means that we pursue our corporate objectives from a long-term perspective while clearly addressing social and ecological concerns. We believe that proactive administration of our social and ecological duties is not a means to compensate for our economic actions, but rather is one of the key drivers of our success.
Who we are
The Sartorius Group is a leading international partner of life science research and the biopharmaceutical industry. With innovative laboratory instruments and consumables, the Group’s Lab Products & Services Division concentrates on serving the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The Bioprocess Solutions Division with its broad product portfolio focusing on single-use solutions helps customers to manufacture biotech medications and vaccines safely and efficiently. The Group has been annually growing by double digits on average and has been regularly expanding its portfolio by acquisitions complementary technologies. In fiscal 2020, the company earned sales revenue of some 2.34 billion euros. At the end of 2020, nearly 11,000 people were employed at the Group’s approximately 60 manufacturing and sales sites, serving customers around the globe.
CONTACT INFORMATION
Sartorius
565 Johnson Avenue
Bohemia, NY 11716
UNITED STATES
Phone: +1.800.368.7178
Fax: 631-254-4253
HOT PRODUCTS
- BIOSTAT STR® Generation 3 Bioreactor With BIOBRAIN
- ambr® 250 Modular Bioreactor Vessel
- Single-Use Bioreactor Bag
- Virosart® Media Lab Modules
- CHO Platform Service Package: The Fast Track To IND
- NutriStem® MSC Culture System
- NutriStem® hPSC XF Medium
- Celsius® FFT: Safeguarding Your Drug Substances In Conventional Freeze & Thaw Manufacturing
- Celsius® CFT: Safeguarding Your Drug Substances In Controlled-Rate Freeze & Thaw Manufacturing
- ambr® 250 High Throughput Bioreactor System For Parallel Fermentation Or Cell Culture
- ambr® 250 modular Single-Use Benchtop Bioreactor With Simplified Operation For Increased Productivity
- Virosart® HFHigh-Speed Virus Filtration Datasheet
- Virosart® Max* Virus Pre-Filter Datasheet
- Virosart® CPV Virus Filter Datasheet
- Virosart® Media Upstream Virus Retentive Filter Datasheet
- Virosart® HC Virus Filter Datasheet
- Celsius® FFT | FFTp With Safecore™ Technology
- NutriFreez® D10 Cryopreservation Medium
- NutriCoat™ Attachment Solution
- 4Cell® Nutri-T Medium
- Flexsafe® Pro Mixer Pre-Designed Solutions
- Flexsafe® RM Single Use Bioreactor Bag Datasheet
- ambr® 15 Cell Culture Generation 2
- ambr® 250 Modular Single-Use Benchtop Bioreactor
- Membrane Chromatography
FEATURED ARTICLES AND DOWNLOADS
- Increased Productivity At The mAb Capture Step
- The Critical Steps For Protein Therapeutic Potency Assay Development
- How A Single Provider Can Reduce Protein Biologic Development Risk
- A Multi-Scale Approach To CHO Media Benchmarking
- Improving The Overall Efficiency Of Cell Line Development
- A Look Into The Future Of Bioprocessing
- Simplify Upstream Process Intensification From PD To Manufacturing
- Combining Ambr 15 Cell Culture With Octet Titer Measurements
- Reduce Protein Biologic Development Risk
- Analytical Power Tools Open Upstream Bioprocessing Bottlenecks
- Cell Line Development: Accelerating Antibody Discovery With The Octet® Platform
- Cell Line Development Toolbox For Intensified Bioprocessing
- Comparison Of HIC Monolithic Support For Sample Displacement Chromatography Of pDNA
- Increasing Productivity Of pDNA DSP Using Sample Displacement Chromatography
- Single Cell Passaging With NutriStem® hPSC XF On Laminin-521 Without The Need For ROCK Inhibitor
- A Xeno-Free Culture System For hMSC From Various Sources Suitable For Initial Isolation And Expansion Toward Clinical Applications
- Efficient Transition Of Human Pluripotent Stem Cell Cultures From Essential 8™ Medium Into NutriStem® hPSC XF Medium On Matrigel®
- From Cells To Organs – The Organoid Stepping-Stone
- Efficient Transition Of Human Pluripotent Stem Cell Cultures From StemFlex™ Medium Into NutriStem® hPSC XF Medium On Matrigel®
- Efficient Transition Of Human Pluripotent Stem Cell Cultures From Essential 8™ Medium Into NutriStem® hPSC XF Medium On Vitronectin
- A Unique Defined Pre-Coating - Free Culture Platform For Isolation And Expansion Of hMSC Towards Clinical Applications
- A Guide To Accelerating Cell Line Development For Commercial Production
- Enabling Broader Adoption Of Process Intensification In Biopharma
- Managing Frozen Transport Logistics In The Biopharma
- Qualification Summary: Shippers For Celsius® FFT | FFTp 12L With Safecore™ Technology
- In-Process Control Of pDNA Production On CIMac™ pDNA Analytical Column
- Fully Single-Use Virus Filtration In Manufacturing
- Protein A Resin Reduction Achieved With Process Transfer From Batch To BioSMB
- Extraction of mRNA From IVT Mixtures With CIMmultus® Oligo dT Column
- Purification Of mRNA By Affinity Chromatography On CIMmultus® Oligo dT Column
- N-1 Perfusion High Inoculum Fed-Batch For Reduced COGS And Easy Retrofit
- Increased Productivity With Concentrated Fed-Batch
- Optimizing Upstream And Downstream Intensification
- Intensified Seed Train Strategy For Faster, Cost-Effective Scale-Up Of Biologics Manufacturing
- Integrated Platform For Intelligent Upstream Process Intensification
- Real World Experience: Modular Facilities, Smaller Footprint With Dynamic Perfusion
- Impact Of A Chemically Defined Medium For Vero Cells Cultivation And Virus Production For Vaccine Applications
- Can mRNA Disrupt The Biopharma Industry?
- Quantifying Viruses? Here’s What Matters Most
- Sartorius Stedim Biotech Launches New Services For Mammalian Cell Bank Manufacturing
- GMP Manufacturing Facility For Viral Vector Production